SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-002074
Filing Date
2023-01-09
Accepted
2023-01-09 08:10:22
Documents
15
Period of Report
2023-01-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm232596d1_8k.htm   iXBRL 8-K 29010
2 EXHIBIT 99.1 tm232596d1_ex99-1.htm EX-99.1 53199
7 GRAPHIC tm232596d1_ex99-1img001.jpg GRAPHIC 3774
  Complete submission text file 0001104659-23-002074.txt   317230

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rigl-20230109.xsd EX-101.SCH 3262
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rigl-20230109_def.xml EX-101.DEF 26440
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE rigl-20230109_lab.xml EX-101.LAB 36200
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rigl-20230109_pre.xml EX-101.PRE 25098
9 EXTRACTED XBRL INSTANCE DOCUMENT tm232596d1_8k_htm.xml XML 4739
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

IRS No.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-29889 | Film No.: 23516701
SIC: 2834 Pharmaceutical Preparations